Human Platelet-Rich Plasma Regulates Canine Mesenchymal Stem Cell Migration through Aquaporins.
Journal
Stem cells international
ISSN: 1687-966X
Titre abrégé: Stem Cells Int
Pays: United States
ID NLM: 101535822
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
07
2022
revised:
19
04
2023
accepted:
05
05
2023
medline:
24
5
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
epublish
Résumé
Platelet products are commonly used in regenerative medicine due to their effects on the acceleration and promotion of wound healing, reduction of bleeding, synthesis of new connective tissue, and revascularization. Furthermore, a novel approach for the treatment of damaged tissues, following trauma or other pathological damages, is represented by the use of mesenchymal stem cells (MSCs). In dogs, both platelet-rich plasma (PRP) and MSCs have been suggested to be promising options for subacute skin wounds. However, the collection of canine PRP is not always feasible. In this study, we investigated the effect of human PRP (hPRP) on canine MSCs (cMSCs). We isolated cMSCs and observed that hPRP did not modify the expression levels of the primary class of major histocompatibility complex genes. However, hPRP was able to increase cMSC viability and migration by at least 1.5-fold. hPRP treatment enhanced both Aquaporin (AQP) 1 and AQP5 protein levels, and their inhibition by tetraethylammonium chloride led to a reduction of PRP-induced migration of cMSCs. In conclusion, we have provided evidence that hPRP supports cMSC survival and may promote cell migration, at least through AQP activation. Thus, hPRP may be useful in canine tissue regeneration and repair, placing as a promising tool for veterinary therapeutic approaches.
Identifiants
pubmed: 37223543
doi: 10.1155/2023/8344259
pmc: PMC10202607
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8344259Informations de copyright
Copyright © 2023 Alessia Parascandolo et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Stem Cell Res Ther. 2021 Jul 13;12(1):392
pubmed: 34256844
Stem Cells Int. 2019 Oct 31;2019:1234263
pubmed: 31781232
Oncol Lett. 2020 Mar;19(3):1665-1672
pubmed: 32194658
J Cell Physiol. 2018 Aug;233(8):6241-6249
pubmed: 29345324
Pflugers Arch. 2008 Jul;456(4):693-700
pubmed: 17968585
BMC Vet Res. 2021 Dec 18;17(1):388
pubmed: 34922529
Acta Cir Bras. 2020 Nov 23;35(10):e202001006
pubmed: 33237177
Oncotarget. 2018 Feb 07;9(20):15228-15238
pubmed: 29632639
J Cell Biochem. 2015 Oct;116(10):2408-18
pubmed: 26012576
Materials (Basel). 2019 Jul 18;12(14):
pubmed: 31323844
Biomolecules. 2021 Jun 22;11(7):
pubmed: 34206204
Platelets. 2018 Jul;29(5):463-467
pubmed: 28635382
J Anim Sci. 2015 Sep;93(9):4436-42
pubmed: 26440343
Front Vet Sci. 2016 Jan 05;2:73
pubmed: 26779493
Platelets. 2014;25(4):252-6
pubmed: 23855408
Stem Cells Int. 2017;2017:2156478
pubmed: 29387089
J Funct Biomater. 2012 Aug 09;3(3):556-68
pubmed: 24955632
Cells. 2021 Jul 08;10(7):
pubmed: 34359898
Oncotarget. 2017 Nov 20;8(65):109000-109017
pubmed: 29312586
Stem Cells. 2007 May;25(5):1270-8
pubmed: 17255520
J Cell Physiol. 2007 Nov;213(2):341-7
pubmed: 17620285
Front Vet Sci. 2020 Oct 26;7:575449
pubmed: 33195571
Front Vet Sci. 2020 Aug 13;7:510
pubmed: 32903517
BMC Vet Res. 2019 Jul 30;15(1):269
pubmed: 31362739
Nat Rev Endocrinol. 2010 Apr;6(4):195-213
pubmed: 20195269
Stem Cells Int. 2017;2017:5946527
pubmed: 29270200
Stem Cells Int. 2022 Oct 20;2022:3852898
pubmed: 36311042
Lab Anim. 2015 Jul;49(3):209-14
pubmed: 25586936
Annu Rev Med. 2012;63:303-16
pubmed: 22248325
BMC Cancer. 2022 Feb 15;22(1):171
pubmed: 35168555
Regen Ther. 2020 Nov 01;15:226-235
pubmed: 33426223
Cell Motil Cytoskeleton. 2009 May;66(5):237-47
pubmed: 19347962
Biochim Biophys Acta Mol Cell Res. 2020 Jan;1867(1):118569
pubmed: 31676353
PLoS One. 2011;6(12):e28492
pubmed: 22145049
Mater Sci Eng C Mater Biol Appl. 2022 Apr;135:112695
pubmed: 35581070
J Clin Med. 2018 Oct 15;7(10):
pubmed: 30326618
Int J Mol Sci. 2020 Oct 21;21(20):
pubmed: 33096812
J Adv Vet Anim Res. 2020 Sep 01;7(3):554-565
pubmed: 33005683
Tissue Eng Part B Rev. 2008 Sep;14(3):249-58
pubmed: 18601587
J Tissue Eng Regen Med. 2020 May;14(5):701-713
pubmed: 32174023
Cancers (Basel). 2022 Nov 03;14(21):
pubmed: 36358839
Animals (Basel). 2020 May 09;10(5):
pubmed: 32397372
FASEB J. 2006 Nov;20(13):2402-4
pubmed: 17015410
Trends Mol Med. 2012 Feb;18(2):128-34
pubmed: 22118960
Animals (Basel). 2020 Jan 25;10(2):
pubmed: 31991713
Mol Pharmacol. 2000 May;57(5):1021-6
pubmed: 10779387
Stem Cells. 2017 Jan;35(1):117-134
pubmed: 27641055